Literature DB >> 3919969

Intramucosal activation of pepsinogens in the pathogenesis of acute gastric erosions and their prevention by the potent semisynthetic amphipathic inhibitor pepstatinyl-glycyl-lysyl-lysine.

T F Ford, D A Grant, B M Austen, J Hermon-Taylor.   

Abstract

This study was designed to test the proposal that a critical event in the formation of acute gastric erosions is the intramucosal activation of pepsinogens. Gastric erosions were induced in rats by controlled haemorrhagic shock. Free acid proteinase activity in homogenates of gastric mucosa taken to include erosions increased progressively throughout the period of hypotension. Free enzyme activity in homogenates of apparently normal mucosa between erosions remained substantially unchanged. Luminal pepstatin, the potent but hydrophobic specific acid proteinase inhibitor which does not penetrate gastric mucosa, did not prevent the development of erosions. The equally potent but amphipathic water-soluble analogue pepstatinyl-gly-lys-lys, which does penetrate gastric mucosa, substantially reduced mucosal ulceration in this system. These findings suggest that focal intramucosal pepsinogen activation at the site of acute experimental erosions is causally related to their development, and suggest the inclusion of potent water soluble acid proteinase inhibitors of appropriate molecular structure in their clinical prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919969     DOI: 10.1016/0009-8981(85)90017-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Effect of stress on the antioxidant enzymes and gastric ulceration.

Authors:  D Das; R K Banerjee
Journal:  Mol Cell Biochem       Date:  1993-08-25       Impact factor: 3.396

Review 2.  [MSI testing : What is new? What should be considered? German version].

Authors:  Josef Rüschoff; Gustavo Baretton; Hendrik Bläker; Wolfgang Dietmaier; Manfred Dietel; Arndt Hartmann; Lars-Christian Horn; Korinna Jöhrens; Thomas Kirchner; Ruth Knüchel; Doris Mayr; Sabine Merkelbach-Bruse; Hans-Ulrich Schildhaus; Peter Schirmacher; Markus Tiemann; Katharina Tiemann; Wilko Weichert; Reinhard Büttner
Journal:  Pathologe       Date:  2021-05-27       Impact factor: 1.011

3.  Pepsin concentration in gastroduodenal biopsy homogenates in chronic ulcer disease.

Authors:  F Vianello; F Di Mario; M Plebani; B Germana; P Dal Santo; G Leandro; P Dotto; S A Grassi; G Battaglia; R Naccarato
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

4.  Prevention of acute gastric erosions in the rat by novel semi-synthetic amphipathic analogues of pepstatin.

Authors:  S P Huddy; G Patel; G C Heywood; B M Austen; J Hermon-Taylor
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

Review 5.  Pepsin and the esophagus.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun

Review 6.  Peptic activity and gastroduodenal mucosal damage.

Authors:  J P Raufman
Journal:  Yale J Biol Med       Date:  1996 Jan-Feb

7.  Determining sequencing depth in a single-cell RNA-seq experiment.

Authors:  Martin Jinye Zhang; Vasilis Ntranos; David Tse
Journal:  Nat Commun       Date:  2020-02-07       Impact factor: 14.919

8.  HDMAC: A Web-Based Interactive Program for High-Dimensional Analysis of Molecular Alterations in Cancer.

Authors:  Chung Chang; Chan-Yu Sung; Han Hsiao; Jiabin Chen; I-Hsuan Chen; Wei-Ting Kuo; Lung-Feng Cheng; Praveen Kumar Korla; Ming-Jhe Chung; Pei-Jhen Wu; Chia-Cheng Yu; Jim Jinn-Chyuan Sheu
Journal:  Sci Rep       Date:  2020-03-03       Impact factor: 4.379

9.  Global computational alignment of tumor and cell line transcriptional profiles.

Authors:  Allison Warren; Yejia Chen; Andrew Jones; Tsukasa Shibue; William C Hahn; Jesse S Boehm; Francisca Vazquez; Aviad Tsherniak; James M McFarland
Journal:  Nat Commun       Date:  2021-01-04       Impact factor: 14.919

10.  Cancer prognosis with shallow tumor RNA sequencing.

Authors:  Pedro Milanez-Almeida; Andrew J Martins; Ronald N Germain; John S Tsang
Journal:  Nat Med       Date:  2020-02-10       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.